FDA Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress
News
March 4, 2025
Bonus Biogroup Announces U.S. Food and Drug Administration (FDA) Clearance of an Investigational New Drug (IND) Application for MesenCure™ Phase III Clinical Study in Respiratory Distress.
Categories
- Blog (87)
- News (48)
- Recruitment (19)
- New Products & Technologies (54)
- Training & Webinar (26)
- Virtual Booth (1)